Joly, Pascal
CHU Rouen Normandie,
France
2025 Rank: 50368
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 184 out of 61090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50368 | 52152 |
| Total Cites | 1532 | 1791 |
| H-index | 18 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 193 | 220 |
| Number of Single+First+Last Authored Papers | 212 | 212 |
| Total Cites to Single+First+Last Authored Papers | 425 | 493 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1082 | 1196 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.50 |
| Self-Citation Percentage |
14.46%
|
|
Joly, Pascal
CHU Rouen Normandie,
France
2024 Rank: 54931
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 189 out of 57585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54931 | 43273 |
| Total Cites | 1451 | 1740 |
| H-index | 17 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 2 | 4 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 197 | 239 |
| Number of Single+First+Last Authored Papers | 211 | 211 |
| Total Cites to Single+First+Last Authored Papers | 406 | 494 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1021 | 1131 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.54 |
| Self-Citation Percentage |
16.61%
|
|
Joly, Pascal
CHU Rouen Normandie,
France
2023 Rank: 28916
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 100 out of 54095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28916 | 24219 |
| Total Cites | 1529 | 1908 |
| H-index | 18 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 230 | 289 |
| Number of Single+First+Last Authored Papers | 199 | 199 |
| Total Cites to Single+First+Last Authored Papers | 451 | 548 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1062 | 1187 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.61 |
| Self-Citation Percentage |
19.86%
|
|
Joly, Pascal
CHU Rouen Normandie,
France
2022 Rank: 38022
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 136 out of 51411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38022 | 34691 |
| Total Cites | 1365 | 1656 |
| H-index | 17 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 188 | 224 |
| Number of Single+First+Last Authored Papers | 199 | 199 |
| Total Cites to Single+First+Last Authored Papers | 393 | 468 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 984 | 1109 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.49 |
| Self-Citation Percentage |
17.57%
|
|
Joly, Pascal
CHU Rouen Normandie,
France
2021 Rank: 32238
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 112 out of 49699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32238 | 31105 |
| Total Cites | 1978 | 2356 |
| H-index | 22 | 24 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 303 | 349 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 558 | 647 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1411 | 1566 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.50 |
| Self-Citation Percentage |
16.04%
|
|
Joly, Pascal
CHU Hopitaux de Rouen,
France
2020 Rank: 33163
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 107 out of 41196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33163 | 34845 |
| Total Cites | 1440 | 1694 |
| H-index | 19 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 67 | 67 |
| Total Cites to Single+First Authored Papers | 249 | 276 |
| Number of Single+First+Last Authored Papers | 182 | 182 |
| Total Cites to Single+First+Last Authored Papers | 396 | 439 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 995 | 1102 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.54 |
| Self-Citation Percentage |
14.99%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.